Medicinal product name Betahistine Actavis 24 mg tablets
Pharmaceutical form Tablet
Strength 24 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leafletPDF 01-08-2023
Summary of product characteristicsPDF 01-08-2023
ATC code N07CA01 Other nervous system drugs
Information for Marketing authorisation holdersView

Medicinal products (6)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N20
(24 mg)
PVC/PVDC/Al blister    12-0005-01 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(24 mg)
PVC/PVDC/Al blister    12-0005-02 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N40
(24 mg)
PVC/PVDC/Al blister    12-0005-03 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
 Not available (according to the information provided by wholesalers)
predicted availability date: Apr 30, 2024
currently no information on availability from any wholesaler N50
(24 mg)
PVC/PVDC/Al blister 7.44 
KZSR*
12-0005-04 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N60
(24 mg)
PVC/PVDC/Al blister    12-0005-05 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(24 mg)
PVC/PVDC/Al blister    12-0005-06 Labelling text Labelling text Aug 1, 2023
Labelling text Labelling text Aug 1, 2023
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 12-0005
Date of authorisation Jan 13, 2012
Marketing authorisation holder, country Teva B.V., Netherlands